- Home
- REBN vs PHIO Comparison
REBN vs PHIO Comparison
Compare REBN & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REBN
- PHIO
- Stock Information
- Founded
- REBN 2015
- PHIO 2011
- Country
- REBN United States
- PHIO United States
- Employees
- REBN N/A
- PHIO N/A
- Industry
- REBN Restaurants
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- REBN Consumer Discretionary
- PHIO Health Care
- Exchange
- REBN Nasdaq
- PHIO Nasdaq
- Market Cap
- REBN 13.3M
- PHIO 12.1M
- IPO Year
- REBN 2022
- PHIO N/A
- Fundamental
- Price
- REBN $2.11
- PHIO $2.14
- Analyst Decision
- REBN
- PHIO Strong Buy
- Analyst Count
- REBN 0
- PHIO 3
- Target Price
- REBN N/A
- PHIO $10.67
- AVG Volume (30 Days)
- REBN 57.7K
- PHIO 70.7K
- Earning Date
- REBN 11-18-2025
- PHIO 11-13-2025
- Dividend Yield
- REBN N/A
- PHIO N/A
- EPS Growth
- REBN N/A
- PHIO N/A
- EPS
- REBN N/A
- PHIO N/A
- Revenue
- REBN $6,565,623.00
- PHIO N/A
- Revenue This Year
- REBN $335.98
- PHIO N/A
- Revenue Next Year
- REBN N/A
- PHIO N/A
- P/E Ratio
- REBN N/A
- PHIO N/A
- Revenue Growth
- REBN 14.03
- PHIO N/A
- 52 Week Low
- REBN $1.03
- PHIO $0.97
- 52 Week High
- REBN $8.30
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- REBN 36.65
- PHIO 45.75
- Support Level
- REBN $2.14
- PHIO $2.08
- Resistance Level
- REBN $2.37
- PHIO $2.17
- Average True Range (ATR)
- REBN 0.14
- PHIO 0.09
- MACD
- REBN 0.00
- PHIO -0.01
- Stochastic Oscillator
- REBN 15.31
- PHIO 23.36
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.